Posttreatments Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection

Background. Severe adverse reactions have been observed in individuals with Loa loa infection treated with either diethylcarbamazine (DEC), the drug of choice for loiasis, or ivermectin (IVM), which is used in mass drug administration programs for control of onchocerciasis and lymphatic filariasis i...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2017-04, Vol.64 (8), p.1017-1025
Main Authors: Herrick, Jesica A., Legrand, Fanny, Gounoue, Raceline, Nchinda, Godwin, Montavon, Céline, Bopda, Jean, Tchana, Steve Mbickmen, Ondigui, Bienvenu Etogo, Nguluwe, Konrad, Fay, Michael P., Makiya, Michelle, Metenou, Simon, Nutman, Thomas B., Kamgno, Joseph, Klion, Amy D.
Format: Article
Language:English
Subjects:
ARTICLES AND COMMENTARIES
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. Severe adverse reactions have been observed in individuals with Loa loa infection treated with either diethylcarbamazine (DEC), the drug of choice for loiasis, or ivermectin (IVM), which is used in mass drug administration programs for control of onchocerciasis and lymphatic filariasis in Africa. In this study, posttreatment clinical and immunologic reactions were compared following single-dose therapy with DEC or IVM to assess whether these reactions have the same underlying pathophysiology. Methods. Twelve patients with loiasis and microfilarial counts
ISSN:1058-4838
1537-6591